Quarter Period Statement Of Income

Fuji Pharma Co.,Ltd. - Filing #7610243

Concept 2021-10-01 to
2022-03-31
2020-10-01 to
2021-03-31
Quarter period statement of income
Statement of income
Net sales
17,726,000,000 JPY
17,277,000,000 JPY
Cost of sales
10,050,000,000 JPY
9,613,000,000 JPY
Gross profit (loss)
7,675,000,000 JPY
7,664,000,000 JPY
Selling, general and administrative expenses
4,963,000,000 JPY
4,977,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
2,712,000,000 JPY
2,686,000,000 JPY
Non-operating income
Interest income
0 JPY
0 JPY
Non-operating income
207,000,000 JPY
91,000,000 JPY
Non-operating expenses
Interest expenses
44,000,000 JPY
18,000,000 JPY
Non-operating expenses
53,000,000 JPY
40,000,000 JPY
Ordinary profit (loss)
2,866,000,000 JPY
2,738,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
1,000,000 JPY
Extraordinary income
JPY
154,000,000 JPY
Extraordinary losses
Extraordinary losses
1,000,000 JPY
21,000,000 JPY
Profit (loss) before income taxes
2,865,000,000 JPY
2,871,000,000 JPY
Income taxes - current
848,000,000 JPY
779,000,000 JPY
Income taxes - deferred
182,000,000 JPY
70,000,000 JPY
Income taxes
1,030,000,000 JPY
849,000,000 JPY
Profit (loss)
1,834,000,000 JPY
2,022,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.